Clinic portal
Clinical resources, sample reports and a clinic portal demo.
Your Reticular team
John Yang · CEO
john@reticular.comChristina Ren, MS, CGC · CPO
christina@reticular.comReading time
About 5 minutes
Embryo Report Core: sample report
The patient-facing report, with five illustrative embryos.
5 min
The summary the clinic receives, laid out like a PGT lab report.
3 min
Illustrative · exact format varies by lab
Physician summary
Embryo Report · Core
PGT-A result + single-gene review
Start before or after IVF. No additional embryo biopsy or cycle.
Before an IVF cycle
Both partners collect saliva at home for whole-genome sequencing. Reticular reviews 988 genes linked to infertility and pregnancy loss.
If a relevant inherited finding is identified, Reticular uses compatible PGT-A data from the IVF cycle to assess which embryos inherited it.
After PGT-A testing
Both partners collect saliva at home for whole-genome sequencing.
Reticular reanalyzes the embryos’ existing raw PGT-A data against both parents to assess inheritance. No new embryo sample is taken.
No change to your PGT-A provider is needed if its raw data are compatible; Reticular confirms compatibility before embryo analysis.
Step 03 · Both options
Patients review findings, limitations and questions with our clinical team. The patient and care team see the same report.
Results return to the ordering clinic. Patients who order directly choose clinic sharing during onboarding.
Clinic flow
Choose either ordering option. The patient pays Reticular directly in both.
Option A
The patient orders and pays Reticular directly, then chooses clinic sharing during onboarding.
Open patient ordering link →Option B
Explore physician ordering with sample patients. Contact the Reticular team to set up your clinic’s workspace.
Try the ordering demo →When the physician places the order
01Your clinic
Physician orders; patient added to dashboard
02Patient
Patient activates and pays; results return to the ordering clinic
03Reticular
Reticular handles kits and the data request
04PGT-A lab
PGT-A lab releases existing embryo files
05Reticular
Reticular analyzes; our clinical team reviews
06Patient
Patient reviews the report with our clinical team
07Your clinic
With consent, physician report returns to the clinic
08Your clinic
Patient and care team decide
Patient link
reticular.com/
Both partners are screened across 988 genes tied to infertility and pregnancy loss; a parental finding is then checked in each embryo.
Each embryo’s PGT-A result sits beside its gene review; where the chromosomes already explain the risk, viability genes are not separately assessed.
Per embryo: the gene, the variant and its evidence grade. Carrier findings do not affect the embryo and are never ranked.
Chromosomes and viability genes only: no polygenic scores, no trait predictions.
One row per embryo, ranked chromosome result first, then pregnancy-loss genes: a viability status (no known risks, moderate risk, higher risk or not assessed) and a counselor note on each.
Clinical limitations
Our initial focus is patients with a clinically important question after the standard fertility workup.
01
Two or more losses where the pregnancy tissue or the transferred embryo tested chromosomally normal.
02
Two or more high-quality euploid transfers without implantation.
03
The standard evaluation is complete and normal, and the couple has PGT-A results to read.
Earlier in the journey
Parental screening can begin before IVF; embryo review follows once compatible PGT-A data are available.
For the visit
01
Reticular reviews both partners’ saliva genomes for inherited single-gene findings, then uses compatible PGT-A data to assess inheritance in embryos.
02
You can order directly, or your physician can place the order for you to activate and pay.
03
With your permission, a physician report also goes to your reproductive endocrinologist.
Add your physician’s name before using it.
Lab guides
Choose the labs your clinic sends biopsies to; the guide your patients follow for each one appears here: who they contact, the steps and the email they send.
No labs chosen yet. Patients pick their own lab in their Reticular account and get its guide; choose yours above to see what they are sent.
Method
Maternal whole genome
Paternal whole genome
Embryo · PGT-A markers
Sparse: the markers the PGT-A platform read, nothing new from the embryo.
markers identify inherited stretches of the four parental haplotypes
Inferred embryo genome · one copy from each parent
Inferred sequence: the basis for the gene review.
Common-variant imputation accuracy
85%embryo data alone
98%+with trio phasing
Clinician-deck benchmark; supporting method references are on slide 24.
Embryo Report Core is $1,999, paid by the patient to Reticular; the clinic does not collect payment.
Embryo Report Complete and the Infertility & Pregnancy Loss Panel are also available; both are on the pricing page. Pricing
Clinical fit
No. The PGT-A lab and chromosome result stay unchanged; Core adds a single-gene review of the existing data.
No. Core does not report polygenic scores or trait predictions.
Compatibility depends on the patient’s ability to obtain the raw data files from their PGT-A cycle. We counsel and assist the patient through this process.
Clinic workflow
No. The patient authorizes their PGT-A lab to release the data using Reticular’s lab-specific guide.
About 3–4 weeks, most of it saliva sequencing and the PGT-A data request. Once both are in, our analysis is quick. Kits arrive two to three business days after the order.
No. The patient pays Reticular directly; the clinic does not collect payment.
For physician orders, activation includes consent to return results to the ordering clinic. Patients who order directly choose clinic sharing and name the recipient during onboarding.
Not yet. The physician report arrives as a PDF to attach to the chart.
Laboratory and counseling
Reticular’s CLIA certification and CAP accreditation applications are in progress; neither has been issued. Counseling coverage depends on the patient’s location: an active license is required where state law requires one; other states do not require a genetic counseling license. Reticular is expanding coverage toward all 50 states and confirms availability before scheduling.